- Home
- DSGN vs ATLN Comparison
DSGN vs ATLN Comparison
Compare DSGN & ATLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- ATLN
- Stock Information
- Founded
- DSGN 2017
- ATLN 2014
- Country
- DSGN United States
- ATLN United States
- Employees
- DSGN N/A
- ATLN N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- ATLN
- Sector
- DSGN Health Care
- ATLN
- Exchange
- DSGN Nasdaq
- ATLN NYSE
- Market Cap
- DSGN 208.9M
- ATLN 140.1M
- IPO Year
- DSGN 2021
- ATLN 2021
- Fundamental
- Price
- DSGN $3.67
- ATLN $1.78
- Analyst Decision
- DSGN Hold
- ATLN
- Analyst Count
- DSGN 1
- ATLN 0
- Target Price
- DSGN $4.00
- ATLN N/A
- AVG Volume (30 Days)
- DSGN 89.5K
- ATLN 65.6K
- Earning Date
- DSGN 08-04-2025
- ATLN 08-22-2025
- Dividend Yield
- DSGN N/A
- ATLN N/A
- EPS Growth
- DSGN N/A
- ATLN N/A
- EPS
- DSGN N/A
- ATLN N/A
- Revenue
- DSGN N/A
- ATLN $444,795,409.00
- Revenue This Year
- DSGN N/A
- ATLN N/A
- Revenue Next Year
- DSGN N/A
- ATLN N/A
- P/E Ratio
- DSGN N/A
- ATLN N/A
- Revenue Growth
- DSGN N/A
- ATLN 10.11
- 52 Week Low
- DSGN $2.60
- ATLN $1.68
- 52 Week High
- DSGN $7.77
- ATLN $7.97
- Technical
- Relative Strength Index (RSI)
- DSGN 48.40
- ATLN N/A
- Support Level
- DSGN $3.65
- ATLN N/A
- Resistance Level
- DSGN $4.21
- ATLN N/A
- Average True Range (ATR)
- DSGN 0.23
- ATLN 0.00
- MACD
- DSGN -0.00
- ATLN 0.00
- Stochastic Oscillator
- DSGN 23.81
- ATLN 0.00
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About ATLN ATLANTIC INTERNATIONAL CORP
Atlantic International Corp is a U.S.-based outsourced services and workforce solutions company. The company specializes in permanent, temporary, and temporary-to-permanent placement services in various areas, including accounting and finance, administrative and clerical, hospitality, information technology, legal, light industrial, and medical fields. It also provides productivity consulting and workforce management solutions.